TrialThe Journal of infectious diseases2023

Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study.

Daniel J Stieh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.